Calibra takes $1.4M to for insulin delivery devices

Calibra Medical, a biotech company with an insulin delivery device used to ease diabetes management, has brought in $1.4 million in convertible promissory notes and warrants, according to a filing with the SEC. Based in Redwood City, Calif., the company is backed by Canaan Partners, Intersouth Partners, Skyline Ventures, Frazier Healthcare Ventures, and Three Arch Partners. It last raised funds in August 2008 amounting to $35 million.